Esperion Therapeutics Inc (ESPR) — Capital Reinvestment Ratio

Latest as of March 2024: 0.00x

Esperion Therapeutics Inc (ESPR) has a Capital Reinvestment Ratio of 0.00x as of March 2024, meaning it reinvests 0% of its operating cash flow ($53.83 Million) in capital expenditures ($73.00K). See ESPR net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$53.83 Million

USD

Capital Expenditures

$73.00K

USD

Data as of

Mar 2024

Most recent filing

Annual Capital Reinvestment Ratio for Esperion Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Esperion Therapeutics Inc from None to None. For live market cap and broader valuation context, see ESPR company net worth.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow